Active Specific Immunotherapy (ASI) and Gcmaf Forte in Management of Metastatic Invasive Carcinoma – Overview of the Therapeutic Modalities and A case Report
Active Specific Immunotherapy (ASI) and Gcmaf Forte in Management of Metastatic Invasive Carcinoma – Overview of the Therapeutic Modalities and A case Report
Authors: Dr. Roni Moya, Prof. Dr. Mike K.S. Chan, Dr. Dmytro Klokol and Dr. Patricia Pan
Publisher: Journal of Clinical & Experimental Immunology; 3(2), 2018
View PDF (EN)View PDF (CN)View PDF (AR)